Search results
Results from the WOW.Com Content Network
The healthcare reform in China refers to the previous and ongoing healthcare system transition in modern China. China's government, specifically the National Health and Family Planning Commission (formerly the Ministry of Health ), plays a leading role in these reforms.
The 2023 Chinese healthcare reform protests were a series of simultaneous pensioner protests in the months that followed China's 2022 COVID-19 protests and the subsequent end of China's zero-COVID policies. On 15 February 2023, simultaneous mass protests of mostly elderly pensioners broke out in both Wuhan and Dalian.
The report suggests that without health care reforms the spending on health care in China will increase to 9% of China's GDP by 2035 which is an increase from the 5.6% of China's GDP in 2014. [34] With substantial urbanization, attention to health care has changed.
Jiuzhou Hospital in Guizhou, China. Health in China is a complex and multifaceted issue that encompasses a wide range of factors, including public health policy, healthcare infrastructure, environmental factors, lifestyle choices, and socioeconomic conditions.
As a result, urban areas saw a rising need for access to affordable healthcare. [10] Beginning in 1995, the government began healthcare reforms and encouraged local experiments. [1]: 276 In 1996, the government stated that it would establish a new healthcare system in which each city would provide health insurance to urban workers.
A majority of GE HealthCare's revenue in China comes from the sales of ultrasound and imaging devices, with the Chinese market accounting for 14.2% of its total revenue in 2023.
China is a member of the World Health Organization. [3] Minister Ma reported in the 92nd World Health Assembly, since 1978, China has been focused on improving primary healthcare, develop universal safety net for residents and improving the quality, efficiency and access to primary health care. [3]
The Nation Healthcare Security Administration (Chinese: 国家医疗保障局), abbreviated as NHSA (Chinese: 医保局) is a deputy-ministerial-level government agency directly under the State Council of the People's Republic of China. The current director is Zhang Ke.